Case Report: Secondary bilateral parkinsonism and dystonia treated with dronabinol
Open Access
- 21 September 2020
- journal article
- Published by F1000 Research Ltd in F1000Research
- Vol. 9, 1162
- https://doi.org/10.12688/f1000research.26476.1
Abstract
Drug abuse may damage basal ganglia that are essential for planning and execution of movements. We report a 38-year old patient with ischemic lesions of the basal ganglia presenting with bilateral painful dystonia and parkinsonism caused by polyintoxication. Dronabinol resulted in improvement of pain and gait disturbance, suggesting a novel therapeutic strategy in these challenging patients.Keywords
This publication has 9 references indexed in Scilit:
- Non‐Motor Symptoms in Parkinson's Disease are Reduced by NabiloneAnnals of Neurology, 2020
- Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?Frontiers in Pharmacology, 2018
- Cannabis can augment thrombolytic properties of rtPA: Intracranial hemorrhage in a heavy cannabis userThe American Journal of Emergency Medicine, 2017
- Medical Cannabis in Parkinson Disease: Real-Life Patients' ExperienceClinical Neuropharmacology, 2017
- Stroke and methamphetamine use in young adults: a reviewJournal of Neurology, Neurosurgery & Psychiatry, 2017
- The neuropathology of drug abuseCurrent Opinion in Behavioral Sciences, 2017
- Cocaine induced hippocampi infarctionBMJ Case Reports, 2012
- Review: The neuropathology of drug abuseNeuropathology and Applied Neurobiology, 2011
- Ballistic movements due to ischemic infarcts after intravenous heroin overdose: report of two casesClinical Neurology and Neurosurgery, 1997